Dose-dense chemotherapy in nonmetastatic breast cancer: a systematic review and meta-analysis of randomized controlled trials. - Wikidata - wikimedia - TriplyDB

Dose-dense chemotherapy in nonmetastatic breast cancer: a systematic review and meta-analysis of randomized controlled trials.

Dose-dense chemotherapy in nonmetastatic breast cancer: a systematic review and meta-analysis of randomized controlled trials.

http://www.wikidata.org/entity/Q33753705

about

Adjuvant Dose-Dense Chemotherapy in Breast Cancer: Standard of Care in High-Risk Patients Triple negative breast cancer: looking for the missing link between biology and treatments Progress in adjuvant chemotherapy for breast cancer: an overview German Adjuvant Intergroup Node-positive Study (GAIN): A Phase III Trial Comparing Two Dose-Dense Regimens (iddEPC vs. ddEC-PwX) in High-Risk Early Breast Cancer Patients.Phase III randomized trial of dose intensive neoadjuvant chemotherapy with or without G-CSF in locally advanced breast cancer: long-term results Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study.Dose-dense paclitaxel versus docetaxel following FEC as adjuvant chemotherapy in axillary node-positive early breast cancer: a multicenter randomized study of the Hellenic Oncology Research Group (HORG).Optimal approach in early breast cancer: Adjuvant and neoadjuvant treatment.Model-based meta-analysis for quantifying Paclitaxel dose response in cancer patients.Organizing medical oncology care at a regional level and its subsequent impact on the quality of early breast cancer management: a before-after study Adjuvant chemotherapy in breast cancer: To use or not to use, the anthracyclines Chemotherapy in early breast cancer: when, how and which one?Accelerated BEP: a phase I trial of dose-dense BEP for intermediate and poor prognosis metastatic germ cell tumour.CHOP-like-14 compared to CHOP-like-21 for patients with aggressive lymphoma--a meta-analysis of randomized controlled trials.Uptake and economic impact of first-cycle colony-stimulating factor use during adjuvant treatment of breast cancer.A way forward on the medically appropriate use of white cell growth factors Being Pregnant and Diagnosed with Breast Cancer.A nested cohort study of 6,248 early breast cancer patients treated in neoadjuvant and adjuvant chemotherapy trials investigating the prognostic value of chemotherapy-related toxicities.A genome-wide association study identifies WT1 variant with better response to 5-fluorouracil, pirarubicin and cyclophosphamide neoadjuvant chemotherapy in breast cancer patients Is it time for a new paradigm for systemic cancer treatment? Lessons from a century of cancer chemotherapy Treatment of breast cancer in young women: do we need more aggressive therapies?Long-term survival of advanced triple-negative breast cancers with a dose-intense cyclophosphamide/anthracycline neoadjuvant regimen.Critical issues on high-dose chemotherapy with autologous hematopoietic progenitor cell transplantation in breast cancer patients.Adjuvant treatments for triple-negative breast cancers.Breakthroughs in research and treatment of early breast cancer: an overview of the last three decades.Neutropenia and relative dose intensity on adjuvant FOLFOX chemotherapy are not associated with survival for resected colon cancer.Feasibility of two schedules of weekly paclitaxel in HER2-negative early breast cancer in a Brazilian community setting.Granulocyte colony-stimulating factors as prophylaxis against febrile neutropenia.Adjuvant Capecitabine in Combination With Docetaxel, Epirubicin, and Cyclophosphamide for Early Breast Cancer: The Randomized Clinical FinXX Trial.Breast cancer under age 40: a different approach.Adjuvant dose-dense chemotherapy in breast cancer: a systematic review and meta-analysis of randomized trials.Exploring the safety of chemotherapy for treating breast cancer during pregnancy.Early breast cancer: diagnosis, treatment and survivorship.Pegfilgrastim for the prevention of chemotherapy-induced febrile neutropenia in patients with solid tumors.Risk of chemotherapy-induced amenorrhea in patients with breast cancer: a systematic review and meta-analysis.News on the medical treatment of young women with early-stage HER2-negative breast cancer.Multidisciplinary Management of Breast Cancer During Pregnancy.Neoadjuvant Therapy for Breast Cancer: Established Concepts and Emerging Strategies.If Chemotherapy Is Indicated, Give the Optimal Regimen!High-Dose Chemotherapy With Autologous Hematopoietic Stem Cell Transplantation for High-Risk Primary Breast Cancer.

P2860

Q26751253-3919E9EA-1350-45A0-8C27-B233F88411BD Q26783122-8A9D7820-8503-4614-A28F-CDF77AEC1B11 Q26798078-80BDA232-1447-40C3-8A70-DEE4A927FD77 Q30313214-40129F69-0F46-43EF-BD60-1CCBFB6CADAF Q33397922-18187C6C-1E86-4509-B68D-F4C69F1E808C Q33408942-E5C1938F-E669-499D-B283-6AD6C7389774 Q33418714-FEF77E1F-165A-4F94-835E-F906A6244C0D Q33698446-C93253EB-8998-4241-A47D-E7ED1D82C64B Q33749066-09CC7F73-07F2-4363-B86D-09663387E6DE Q34000716-9F233970-A827-42B0-988A-BA914FF0DAD3 Q34023749-6B509F9D-C739-4883-8C2F-EA733E7125B6 Q34042640-4B60CB89-90ED-4AD6-B6BF-A4BAAE920C24 Q35208183-1A981B4E-39DB-452E-9564-FC17FBFA5647 Q35638549-1EBCB46E-9108-43A9-8A3D-62E1D8A3A637 Q35808451-9756E3A7-3E49-43A7-8BF6-80B914B2D53F Q36058245-B0C172C5-FA6E-418D-8308-D3C97EF7743E Q36131343-B706F6E7-40FF-4D95-884D-61CE56B07CBF Q36409909-7BE0AF06-2DAF-4750-8CF0-50B3AE8B24AE Q36782669-40F47948-3B8C-482C-9973-577A9ACF90C8 Q36952188-C706ABA6-8209-4CD7-9AC9-215FDC125952 Q36963389-F588F0CD-31F6-484E-939E-9339871163FB Q37650748-FE42654D-FD41-49C1-B642-6A1D15F068F6 Q38040419-B9F99BE8-329A-440D-A0D9-C942A04CE533 Q38046581-8B3090D9-FC4C-4058-A25A-29A03E1D33F4 Q38159974-BD23D443-22EA-4A8A-8F32-6991506AA3F2 Q38228214-602273BF-1297-4F3C-99B9-DDE0F5E2245B Q38252374-3573143A-C4FD-4763-AFFF-689A04006B7B Q38256944-5CB9E321-7F5F-451E-BB3E-739B929510B5 Q38380059-E1FF268C-2F53-463B-A8E0-8AE7832984EB Q38386346-4E41D5BE-89D9-4261-8400-1E510C5F8FC7 Q38445535-DE6E6930-C626-40E1-8F4E-79001F333CD8 Q38539265-FC7987D0-D5F8-4CBF-AC8C-D9B001E4ED10 Q38566352-9FA04B3A-78D8-45C1-8E87-BB3662A6DB66 Q38613025-DE11435E-D851-4430-8D84-21467FE08A24 Q38814894-C812FEE7-8893-4A77-BBCF-CD4FA637265E Q38870541-A25F1D12-05BF-4C49-ABD5-0AEE23B42DC5 Q38945176-C748EF95-22AE-4482-A185-DE6707FEF553 Q39375196-9CE0B171-51FA-404C-83AD-28D2827C099B Q39681143-DB28E469-F588-4DCE-BBB2-428AB330EA07 Q40847140-4B54A8D6-D63A-4B22-9D40-5F40547AA013

P2860

Dose-dense chemotherapy in nonmetastatic breast cancer: a systematic review and meta-analysis of randomized controlled trials.

http://www.wikidata.org/entity/Q33753705

description

2010 nî lūn-bûn

@nan

2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Dose-dense chemotherapy in non ...... randomized controlled trials.

@ast

Dose-dense chemotherapy in non ...... randomized controlled trials.

@en

type

label

Dose-dense chemotherapy in non ...... randomized controlled trials.

@ast

Dose-dense chemotherapy in non ...... randomized controlled trials.

@en

prefLabel

Dose-dense chemotherapy in non ...... randomized controlled trials.

@ast

Dose-dense chemotherapy in non ...... randomized controlled trials.

@en

P1433

Q33753705-49E9AA02-7E90-4807-87E5-5DC501555586

P1476

Q33753705-13DAF54B-0BF0-4743-9167-F69AA8E7B10E

P2093

Q33753705-14F0241B-ED4E-4CC9-A92E-A7CBDC2DE573

Q33753705-2D9EB1D4-88AC-4540-B128-AE07C2CF307F

Q33753705-8E79A7DE-AF43-4C7C-AC3C-277ABC66E6A9

Q33753705-9A6615BD-F04A-4BD6-AE99-EBE151541E94

Q33753705-F0604BE3-400E-4218-95A3-973B1524F362

P275

Q33753705-008D183A-00DA-4C91-BFCB-BB3F5299221A

P2860

Q33753705-03D008AF-8F7D-40FF-850F-4D8D5CF8AF49

Q33753705-144925C0-9C67-4ED7-9663-2AC707D6E852

Q33753705-1A48ACE8-D7B0-48D0-B030-3C8744C1716B

Q33753705-2581F294-D37F-41A2-8680-C51E0116AE0B

Q33753705-25F5921A-0B23-40B1-9DCD-E8B3DE75DAD0

Q33753705-378F0DEA-5ED1-4555-8B9D-25D30336EE22

Q33753705-6C398942-FC8E-4823-8B0E-8EA3353516BD

Q33753705-6EA898AA-94B9-4DF8-9EED-F66E617683B6

Q33753705-717E7441-1B3D-4D65-AB1B-31E5D65A3527

Q33753705-71EAA72E-14A7-4AC6-9225-F5A3C5372B14

P304

Q33753705-B9AFCC70-7208-4CF0-A63F-961AD0E67FA4

P31

Q33753705-5E41DB98-67A3-4DAB-BDCE-2DDDE31F6A54

Q33753705-C63990D4-F431-4E95-AA90-C4FAA31EC1E5

Q33753705-cae275ce-ce40-42b8-a5da-fccc16490187

P356

Q33753705-219C0B43-44C9-4ECF-A50E-7495636D5520

P407

Q33753705-BDFE7AEE-6844-4F1B-8061-46C30C26CCBC

P433

Q33753705-EDE7E787-950D-47E2-AC4A-3BABAF1D3BD2

P478

Q33753705-29391BBA-4D85-47CE-A0D4-BA093B173314

P50

Q33753705-70D274E9-8D7E-4B23-BF08-0A5D65E76649

P5008

Q33753705-FB0738AF-18B4-43E1-AE7D-825CE3FCEC0B

P577

Q33753705-038F8EF0-695E-457C-9261-37A1ECEBF719

Q33753705-8DFC2CDF-2AB6-449F-A661-88F0C5296A62

P5875

Q33753705-FB14731D-5758-4907-BB78-728445F4C656

P698

Q33753705-20D8390B-78C9-4501-BFBF-FDC06133EBDB

P921

Q33753705-019F5AFC-BD7E-4728-BAB5-104397A4EC8F

Q33753705-1FA95B81-95E4-46A9-8E29-D8E194E81823

Q33753705-58821D5A-24F4-4089-BBE7-DBA980B3B6E0

Q33753705-D084629C-C237-44B5-B3A5-ABC2B3E152B1

P932

Q33753705-E25BABA0-7262-404B-87B3-97B2A2F7B1AF

P356

P1433

Journal of the National Cancer Institute

P1476

Dose-dense chemotherapy in non ...... randomized controlled trials.

@en

P2093

Anat Gafter-Gvili

http://www.w3.org/2001/XMLSchema#string

Irit Ben-Aharon

http://www.w3.org/2001/XMLSchema#string

Liat Vidal

http://www.w3.org/2001/XMLSchema#string

Luisa Bonilla

http://www.w3.org/2001/XMLSchema#string

Salomon M Stemmer

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial

P2860

Bias in meta-analysis detected by a simple, graphical test

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

Operating characteristics of a rank correlation test for publication bias

Meta-analysis in clinical trials

Statistical aspects of the analysis of data from retrospective studies of disease

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

Dose-dense therapy in the treatment of early-stage breast cancer: an overview of the data.

Dose-dense adjuvant chemotherapy in early breast cancer patients: results from a randomized trial.

Intensive dose-dense compared with conventionally scheduled preoperative chemotherapy for high-risk primary breast cancer.

Cyclophosphamide, epirubicin, and Fluorouracil versus dose-dense epirubicin and cyclophosphamide followed by Paclitaxel versus Doxorubicin and cyclophosphamide followed by Paclitaxel in node-positive or high-risk node-negative breast cancer

P304

1845-1854

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JNCI/DJQ409

http://www.w3.org/2001/XMLSchema#string

P407

P433

24

http://www.w3.org/2001/XMLSchema#string

P478

102

http://www.w3.org/2001/XMLSchema#string

P50

Leonard Leibovici

P5008

P577

2010-11-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2010-12-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49629892

http://www.w3.org/2001/XMLSchema#string

P698

21098761

http://www.w3.org/2001/XMLSchema#string

P921

breast neoplasm

biomedical investigative technique

P932

3001963

http://www.w3.org/2001/XMLSchema#string